ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market
January 02, 2025 at 09:00 AM EST
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market
By:
TheNewswire.com
January 02, 2025 at 09:00 AM EST
More NewsView More
Tesla Stock Could Accelerate on New EV Tax Legislation
July 09, 2025
Why Marvell Could Be the Smartest AI Bet Under $80
July 09, 2025
Navigating Solar Headwinds: 3 Stocks Built to Last
July 09, 2025
Autodesk Stock Ready to Rip? Q3 May Be the Turning Point
July 09, 2025
Via MarketBeat
Tickers
UNH
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|